PCSK9

PCSK9

PCSK9 詳細

Molecule Name
Proprotein convertase subtilisin kexin type 9
分子の別称
PCSK9,FH3,HCHOLA3,LDLCQ1,NARC1,PC9
Drug Development Progress
治験薬の数36
市販薬剤の数8
研究&開発段階Approved
ターゲットの別称
EC 3.4.21,Neural apoptosis-regulated convertase 1,Proprotein convertase 9,NARC1,PSEC0052,PCSK9,NARC-1,EC:3.4.21.-,Proprotein Convertase Subtilisin/Kexin Type 9,Subtilisin/Kexin-Like Protease PC9,PC9,Convertase Subtilisin/Kexin Type 9 Preproprotein,Hypercholesterolemia, Autosomal Dominant 3,EC 3.4.21.-,HCHOLA3,LDLCQ1,FH3,EC 3.4.21.111,Neural Apoptosis Regulated Convertase 1,FHCL3
バックグランド
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is also known as NARC1 (neural apoptosis regulated convertase), is a newly identified subtilase belonging to the peptidase S8 subfamily. Mouse PCSK9 is synthesized as a soluble zymogen, and undergoes autocatalytic intramolecular processing in the endoplasmic reticulum, resulting in the cleavage of its propeptide that remains associated with the secreted active enzyme with a broad alkaline pH optimum. This protein plays a major regulatory role in cholesterol homeostasis. PCSK9 binds to the epidermal growth factor-like repeat A (EGF-A) domain of the low-density lipoprotein receptor (LDLR), inducing LDLR degradation. PCSK9 may also have a role in the differentiation of cortical neurons. Mutations in this gene have been associated with a rare form of autosomal dominant familial hypercholesterolemia (HCHOLA3).

PCSK9 製品リスト

Species
  • Human(7)
  • Cynomolgus(2)
  • Mouse(2)
  • Hamster(1)
  • Rat(1)
  • Rhesus macaque(1)
Tag
  • His Tag(9)
  • His Tag & Avi Tag(4)
  • Fc Tag(1)
Host
  • HEK293(14)
Conjugate
  • Unconjugated(10)
  • Biotin-labeled(4)
Grade
  • RUO(14)
Low Endotoxin
  • Yes(4)
  • No(10)
MoleculeCat. No.Product Name種HostStructurePurityActivitySize&Price
PCSK9
Human PCSK9 Protein, His Tag
Human
HEK293
HPLCSDS-PAGE
SPR

$1290.00

250ug
PCSK9
Cynomolgus PCSK9 Protein, His Tag, low endotoxin
Cynomolgus
HEK293
SDS-PAGE
ELISABLI

$270.00

50ug
PCSK9
Human PCSK9 Protein, His Tag, low endotoxin (Mass Spec & MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISASPRBLI

$415.00

50ug
PCSK9
Human PCSK9 Protein, Fc Tag
Human
HEK293
SDS-PAGE
ELISABLI

$300.00

50ug
PCSK9
HOTAvitag
PC9-H82E7
Biotinylated Human PCSK9 Protein, Avitag™,His Tag (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISA

$380.00

25ug
PCSK9
Human PCSK9 (D374Y) Protein, His Tag, low endotoxin (Mass Spec & MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISASPRBLIFlow

$280.00

50ug
PCSK9
HOTAvitag
PCY-H82E7
Biotinylated Human PCSK9 (D374Y) Protein, Avitag™,His Tag
Human
HEK293
SDS-PAGE
ELISA

$360.00

25ug
PCSK9
Rhesus macaque PCSK9 Protein, His Tag
Rhesus macaque
HEK293
SDS-PAGE
ELISABLI

$270.00

50ug
PCSK9
Avitag
PC9-C82E3
Biotinylated Cynomolgus PCSK9 Protein, His,Avitag™ (MALS verified)
Cynomolgus
HEK293
MALSSDS-PAGE
ELISA

$360.00

25ug
PCSK9
Hamster PCSK9 Protein, His Tag
Hamster
HEK293
SDS-PAGE
ELISABLI

$270.00

50ug
You Have Viewed 1-10 Of 14 Results
  • 1
  • 2

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
Recombinant human anti-PCSK9 monoclonal antibody (Salubris)SAL003Phase 3 ClinicalShenzhen Salubris Pharmaceuticals Co Ltd
Dyslipidemias; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias
詳細
SYH-2053SYH2053; SYH-2053Phase 3 ClinicalCSPC Pharmaceutical Group Ltd
Dyslipidemias; Heterozygous familial hypercholesterolemia; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias; Sitosterolemia
詳細
RBD-7022RBD7022; RBD-7022; SR043; SR-043; QLC-7401Phase 3 ClinicalSuzhou Ribo Life Science Co Ltd
Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias; Sitosterolemia
詳細
LaroprovstatAZD-0780; AZD0780Phase 3 ClinicalDogma Therapeutics
Atherosclerosis; Cardiovascular Diseases; Dyslipidemias; Hepatic Insufficiency; Heterozygous familial hypercholesterolemia; Renal Insufficiency
詳細
Enlicitide DecanoateMK-0616Phase 3 ClinicalMerck Sharp & Dohme Corp
Arteriosclerosis; Atherosclerosis; Cardiovascular Diseases; Hepatic Insufficiency; Heterozygous familial hypercholesterolemia; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II; Kidney Diseases; Renal Insufficiency; Sitosterolemia
詳細
AZD-8233AZD-8233; IONIS-AZ4-2.5-LRx; ION-449Phase 2 ClinicalIonis Pharmaceuticals Inc
Dyslipidemias; Hypercholesterolemia; Hyperlipidemias; Kidney Failure, Chronic
詳細
CVI-LM-001CVI-LM-001; CVI-LM001; C-8304Phase 2 ClinicalXiwei'Ai Medicine Technology (Shanghai) Co Ltd
Hypercholesterolemia; Hyperlipidemias
詳細
ATX-304O-304; ATX-304; O-304XPhase 2 ClinicalBetagenon Ab
Diabetes Mellitus, Type 2; Mitochondrial Diseases; Peripheral Arterial Disease
詳細
MIL-86MIL-86Phase 2 ClinicalBeijing Mabworks Biotech Co Ltd
Cardiovascular Diseases; Heterozygous familial hypercholesterolemia; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II
詳細
NNC0385-0434NNC0385-0434; NN-6435; NNC 0385 0434Phase 2 ClinicalNovo Nordisk A/S
Arteriosclerosis; Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Hypercholesterolemia; Renal Insufficiency, Chronic
詳細
ARO-DIMER-PAARO-DIMER-PAPhase 2 ClinicalArrowhead Pharmaceuticals Inc
Hyperlipidemia, Familial Combined; Hyperlipidemias
詳細
BEBT-701BEBT-701Phase 2 ClinicalGuangzhou BeBetter Medicine Technology Co
Hypercholesterolemia; Hyperlipidemias; Hypertension
詳細
DNV-001DNV-001; DNV001Phase 2 ClinicalHangzhou Dingle New Biotechnology Co Ltd
Dyslipidemias; Hypercholesterolemia; Hyperlipidemia, Familial Combined
詳細
YKYY-015YKYY015; YKYY-015Phase 2 ClinicalHangzhou Tianlong Pharmaceutical Co Ltd
Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias
詳細
PCSK9 Inhibitors therapy(Guangdong Provincial People'S Hospital)Phase 2 ClinicalGuangdong Provincial People'S Hospital
Colorectal Neoplasms
詳細
Recombinant human anti-PCSK9 monoclonal antibody (Tasly Pharm)B1655; B-1655Phase 1 ClinicalTianjin Tasly Pharmaceutical Co Ltd
Hypercholesterolemia
詳細
DC-371739JYP-0739; DC-371739Phase 1 ClinicalShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
Dyslipidemias; Hypercholesterolemia; Hyperlipidemias
詳細
Anti-PCSK9 monoclonal antibody (Biocad)Phase 1 ClinicalBIOCAD JSC
Cardiovascular Diseases
詳細
ATH-04ATH-04; Affitope AT04APhase 1 ClinicalAffiris Ag
Atherosclerosis
詳細
VERVE-101VERVE-101Phase 1 ClinicalBroad Institute, Harvard University
Atherosclerosis; Cardiovascular Diseases; Heterozygous familial hypercholesterolemia; Hypercholesterolemia
詳細
ART-002g1ART002g1; ART-002g1Phase 1 ClinicalShanghai Jiao Tong University Affiliated First People'S Hospital
Heterozygous familial hypercholesterolemia
詳細
RN-5681RN-5681; RN5681Phase 1 ClinicalRona Therapeutics Inc
Atherosclerosis; Hypercholesterolemia
詳細
PRD-001PRD001; PRD-001Phase 1 ClinicalPRD Therapeutics Inc
Fatty Liver; Homozygous familial hypercholesterolemia; Metabolic Dysfunction-Associated Steatotic Liver Disease
詳細
ZRC-3306ZRC-3306Phase 1 ClinicalZydus Lifesciences Ltd
Dyslipidemias
詳細
STX-1150STX1150; STX-1150Phase 1 ClinicalScribe Therapeutics Inc
Cardiovascular Diseases; Hypercholesterolemia
詳細
SAL-092SAL092; SAL-092Phase 1 ClinicalShenzhen Salubris Pharmaceuticals Co Ltd
Dyslipidemias; Hypercholesterolemia
詳細
VERVE-102VERVE-102Phase 1 ClinicalVerve Therapeutics Inc
Atherosclerosis; Coronary Disease; Heterozygous familial hypercholesterolemia
詳細
SRSD-101SRSD101; SRSD-101; SRS001; SRS-001Phase 1 ClinicalSirius Therapeutics Inc
Cardiovascular Diseases; Hypercholesterolemia
詳細
SGB-3403SGB-3403Phase 1 ClinicalSuzhou Sanegene Bio Inc
Atherosclerosis; Heterozygous familial hypercholesterolemia; Hypercholesterolemia; Hyperlipidemias
詳細
RN-0191RN0191Phase 1 ClinicalDarui Biomedical Technology (Shanghai) Co Ltd
Atherosclerosis; Dyslipidemias; Hypercholesterolemia
詳細
RP-910RP910; RP-910Phase 1 ClinicalRisen(Shanghai) Pharma Tech Co Ltd
Hyperlipidemias; Metabolic Diseases
詳細
SAL-061YOLT-101; SAL-061; SAL061Phase 1 ClinicalShanghai Yaotang Biotechnology Co Ltd
Heterozygous familial hypercholesterolemia; Hyperlipoproteinemia Type II
詳細
JX-7002JX7002; JX-7002Phase 1 ClinicalZhejiang Jingxin Pharmaceutical Co Ltd
Hypercholesterolemia; Hyperlipidemias
詳細
NN-6434NN-6434Phase 1 ClinicalNovo Nordisk A/S
詳細
PCSK9 modulator (Genekey Biotech)Phase 1 ClinicalShenzhen Salubris Pharmaceuticals Co Ltd
Inflammation; Metabolic Diseases
詳細
ART-002(Ruizheng Gene)ART002; ART-002; ART-002(Ruizheng Gene)ClinicalRuizheng Gene (Suzhou) Co Ltd
Heterozygous familial hypercholesterolemia
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
Inclisiran sodiumALN-60212; PCSK9si; ALN-PCSsc; KJX839; KJX-839ApprovedAlnylam Pharmaceuticals IncLeqvio, 乐可为EUDyslipidemias; HypercholesterolemiaNovartis Europharm Ltd2020-12-09
Acute Coronary Syndrome; Atherosclerosis; Cardiovascular Diseases; Carotid Artery Diseases; Coronary Artery Disease; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Dyslipidemias; Heterozygous familial hypercholesterolemia; Homozygous familial hypercholesterolemia; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II; Hypolipoproteinemias; Myocardial Infarction; Renal Insufficiency; Stroke
詳細
OngericimabJS-002ApprovedShanghai Junshi Biosciences Co Ltd君适达Mainland ChinaHypercholesterolemia; DyslipidemiasShanghai Junshi Biosciences Co Ltd2024-10-09
Atherosclerosis; Dyslipidemias; Heterozygous familial hypercholesterolemia; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias; Hypertriglyceridemia; Neoplasms
詳細
LerodalcibepLIB-003; HST 101ApprovedLib Therapeutics LlcUnited StatesHypercholesterolemiaLIB Therapeutics Inc2025-12-12
Arteriosclerosis; Atherosclerosis; Cardiovascular Diseases; Dyslipidemias; Heterozygous familial hypercholesterolemia; Homozygous familial hypercholesterolemia; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II; Metabolic Diseases; Stroke
詳細
EbronucimabAK-102ApprovedYabao Us Pharmaceutical Co Ltd伊喜宁Mainland ChinaHypercholesterolemia; DyslipidemiasKang Rong Dongfang (Guangdong) Pharmaceutical Co Ltd2024-09-26
Dyslipidemias; Heterozygous familial hypercholesterolemia; Homozygous familial hypercholesterolemia; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias; Hyperlipoproteinemia Type II
詳細
RecaticimabSHR-1209ApprovedJiangsu Hengrui Medicine Co Ltd艾心安Mainland ChinaHypercholesterolemia; DyslipidemiasGuangdong Hengrui Pharmaceutical Co Ltd2025-01-08
Dyslipidemias; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias; Hyperlipoproteinemia Type II; Intracranial Arteriosclerosis
詳細
EvolocumabAMG-145ApprovedAmgen Inc, Astellas Pharma Inc瑞百安, RepathaEUDyslipidemias; HypercholesterolemiaAmgen Europe Bv2015-07-17
Acute Coronary Syndrome; Aortic Aneurysm, Abdominal; Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Coronary Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Dyslipidemias; Glioblastoma; Glioma; Heart Failure, Systolic; Heterozygous familial hypercholesterolemia; HIV Infections; Homozygous familial hypercholesterolemia; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II; Myocardial Infarction; Rejection in heart transplantation; Sepsis; ST Elevation Myocardial Infarction; Stroke
詳細
TafolecimabIBI-306Approved信必乐Mainland ChinaDyslipidemias; HypercholesterolemiaInnovent Biologics(Suzhou) Co Ltd2023-08-15
Aortic Valve Stenosis; Dyslipidemias; Heterozygous familial hypercholesterolemia; Homozygous familial hypercholesterolemia; Hypercholesterolemia; Hyperlipidemias
詳細
Alirocumab316P; REGN-727; SAR-236553ApprovedRegeneron Pharmaceuticals Inc, Sanofi波立达, PraluentUnited StatesHypercholesterolemiaRegeneron Pharmaceuticals Inc2015-07-24
Acute Coronary Syndrome; Angina Pectoris; Atherosclerosis; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus, Type 2; Drinking Behavior; Dyslipidemias; Hemorrhage; Heterozygous familial hypercholesterolemia; HIV Infections; Homozygous familial hypercholesterolemia; Hypercholesterolemia; Hyperlipidemias; Intracranial Arteriosclerosis; Ischemic Stroke; Liver Diseases, Alcoholic; Myocardial Infarction; Plaque, Atherosclerotic; Sepsis; Shock, Septic; ST Elevation Myocardial Infarction; Stroke; Vascular Diseases
詳細
Customer Reviews
  • 1***02019-10-11
    Experiment purpose: antibody screening. Experiment method: Elisa. User experience: I purchased both small and big packages. It is stable from batch to batch and has excellent bioactivity. The experiment results are also very satisfying.